In treating hematologic malignancies, engineered T-cell therapy outperforms standard transplantation with respect to chronic ...

Now, as a scientist at the University of Pennsylvania, Charly is working to rewrite the future of cancer treatment.

Our blood consists of many cell types that develop through different stages from a precursor type—the blood stem cell. An ...

Currently, 13 CAR-T treatments have received regulatory approval. Blood cancers have dominated the development pipeline of ...

Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

New research suggests that frequent blood donation can trigger genetic changes that might protect certain stem cells from ...